欧洲IgA肾病的发病率和患病率
本研究基于欧洲10个国家肾脏活检登记数据,估算IgA肾病年发病率为0.76/10万(全年龄段),点患病率为2.53/万(95%CI 2.51-2.55),儿童和老年人群患病率较低。
要点
- 全年龄段IgA肾病年发病率为0.76/10万。
- 全年龄段点患病率为2.53/万(95%CI 2.51-2.55),各国范围1.14-5.98/万。
- 儿童和老年人群患病率分别为0.12/万和0.36/万,明显低于全年龄段。
核心结论
- 基于欧洲国家登记的高质量数据,全年龄段IgA肾病点患病率估计为2.53/万,儿童和老年人群患病率明显较低。
研究设计与样本
- 研究基于欧洲国家肾脏活检登记数据的文献综述,纳入1990年至2020年发表、经当代技术活检确诊IgA肾病的研究,分全年龄段、儿童和老年三个汇总人群估算发病率和患病率。
主要发现
- 10个欧洲国家全年龄段IgA肾病年发病率为0.76/10万。
- 全年龄段点患病率为2.53/万(95%CI 2.51-2.55),各国从西班牙1.14/万到立陶宛5.98/万不等。
- 按2021年人口估算,10国预期患病病例数为47 027例,从爱沙尼亚577例到意大利16 645例不等。
- 儿童IgA肾病年发病率为0.20/10万,点患病率为0.12/万。
- 老年IgA肾病年发病率为0.30/10万,点患病率为0.36/万。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: This study aimed to determine the incidence and prevalence of immunoglobulin A nephropathy (IgAN) in Europe based on high-quality data from national registries. METHODS: IgAN incidences were obtained from a literature review of European studies of national kidney biopsy registry data in which IgAN diagnosis was biopsy-verified using contemporary techniques. Studies were eligible for the main analysis if published from 1990 to 2020. IgAN point prevalence was defined as the annual IgAN incidence multiplied by the estimated duration of disease. Incidence and prevalence estimates were made for three pooled populations: (i) patients of all ages; (ii) pediatric patients; and (iii) elderly patients. RESULTS: Across 10 European countries, the estimated annual IgAN incidence was 0.76 per 100 000 in patients of all ages. The corresponding pooled IgAN point prevalence was 2.53 per 10 000 (95% confidence interval: 2.51-2.55), ranging from 1.14 per 10 000 in Spain to 5.98 per 10 000 in Lithuania. Applied to 2021 population estimates, the number of expected prevalent IgAN cases was 47 027 across all 10 countries and ranged from 577 in Estonia to 16 645 in Italy. Among pediatric patients, IgAN incidence was 0.20 per 100 000 children and IgAN point prevalence was 0.12 per 10 000 children. Among elderly patients, IgAN incidence was 0.30 per 100 000 and IgAN point prevalence was 0.36 per 10 000. CONCLUSIONS: Based on high-quality data from European national registries, IgAN point prevalence was estimated at 2.53 per 10 000 in patients of all ages. Prevalence was considerably lower in pediatric and elderly populations.
引用
- Willey CJ, Coppo R, Schaefer F, et al. The incidence and prevalence of IgA nephropathy in Europe. Nephrol Dial Transplant. 2023. PMID: 37156519. doi:10.1093/ndt/gfad082
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。